Journal of Ophthalmic Inflammation and Infection
Scope & Guideline
Illuminating the path of ocular inflammation and infection.
Introduction
Aims and Scopes
- Ocular Inflammatory Diseases:
The journal extensively covers various types of ocular inflammatory conditions, including uveitis, scleritis, and keratitis, emphasizing their clinical characteristics, treatment options, and management strategies. - Infectious Ocular Diseases:
Research on infectious diseases affecting the eye such as endophthalmitis, keratitis, and conjunctivitis is a core focus, including investigations into causative pathogens and their susceptibility to treatment. - Innovative Diagnostic Techniques:
The journal promotes the use of advanced diagnostic methods, including imaging technologies like optical coherence tomography and molecular techniques such as PCR, to enhance the accuracy of diagnosis in ophthalmology. - Clinical Case Studies:
The publication features detailed case reports that provide insights into rare and complex ocular conditions, contributing to a better understanding of clinical presentations and treatment outcomes. - Therapeutic Advances:
A significant aim of the journal is to report on new therapeutic approaches, including the use of biologics, corticosteroids, and novel drug delivery systems, aimed at improving patient outcomes in ocular inflammation and infection.
Trending and Emerging
- Impact of COVID-19 on Ocular Health:
There is a growing body of work investigating the ocular manifestations and complications associated with COVID-19, including post-vaccination effects, indicating a heightened awareness and research interest in this area. - Biologics and Novel Therapies:
An increasing number of studies are exploring the use of biologics and new therapeutic agents for managing inflammatory ocular diseases, showcasing the journal's commitment to reporting cutting-edge treatment options. - Microbial Resistance Patterns:
Research focusing on antimicrobial resistance in ocular pathogens is on the rise, reflecting a global concern about treatment efficacy and the need for updated guidelines in managing ocular infections. - Advanced Imaging Techniques:
There is a trend towards more publications utilizing advanced imaging modalities, such as OCT angiography and in vivo confocal microscopy, to enhance diagnostic accuracy and patient management strategies. - Multidisciplinary Approaches in Ocular Disease Management:
The journal is increasingly featuring studies that incorporate a multidisciplinary approach, combining ophthalmology with other medical fields like rheumatology and infectious diseases, to provide holistic patient care.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable decrease in publications focused on conventional surgical methods for treating ocular diseases, possibly due to the rise of less invasive and more effective therapeutic alternatives. - General Microbial Keratitis Studies:
Although still relevant, general studies on microbial keratitis without specific emphasis on emerging pathogens or novel treatment approaches have become less frequent, reflecting a shift towards more targeted investigations. - Non-Infectious Uveitis Studies:
Research specifically dedicated to non-infectious uveitis, particularly studies not involving new treatment protocols or significant case series, appears to be declining in favor of more comprehensive studies involving infectious or complex cases. - Epidemiological Surveys:
The publication of broad epidemiological studies related to ocular infections is decreasing, likely as the focus shifts towards more detailed and actionable clinical research. - Basic Science Research:
There seems to be a reduction in the number of papers focusing on basic science aspects of ocular inflammation and infection, as the journal emphasizes clinical applications and case-oriented research.
Similar Journals
Ocular Surface
Elevating Knowledge in Ocular Surface ScienceOcular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.
Journal of the Korean Ophthalmological Society
Exploring New Horizons in Eye HealthThe Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.
Journal of Ophthalmology
Illuminating Innovations in OphthalmologyThe Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.
Ocular Oncology and Pathology
Advancing Knowledge in Ocular Oncology and PathologyOcular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.
Nepalese Journal of Ophthalmology
Empowering Vision Care with Open Access InsightsNepalese Journal of Ophthalmology, established by the NEPAL OPHTHALMIC SOC, is a premier Open Access journal dedicated to advancing the field of ophthalmology. With its ISSN 2072-6805 and E-ISSN 2091-0320, the journal provides an important platform for sharing innovative research and clinical findings in eye health. Since its inception in 2009, the journal has aimed to disseminate high-quality research that addresses contemporary challenges in ophthalmic practices, thus supporting improved patient care and outcomes within Nepal and beyond. The journal has achieved notable recognition, evidenced by its Scopus rank of #267 out of 915 in the field of General Medicine, placing it within the 70th percentile. Researchers, professionals, and students will find valuable information in its comprehensive articles, which cater to a multidisciplinary audience interested in the latest developments in ophthalmology. Emphasizing accessibility, the journal ensures that all published content is freely available, fostering collaboration and knowledge sharing in the global medical community.
OCULAR IMMUNOLOGY AND INFLAMMATION
Empowering clinicians with essential ocular insights.Ocular Immunology and Inflammation is a distinguished academic journal dedicated to advancing the field of ocular immunology and ophthalmic inflammation. Published by Taylor & Francis Inc, this journal plays a crucial role in disseminating high-quality research findings, reviews, and clinical studies that address the complexities of immune responses in the eye and their implications in various ocular diseases. With an impressive impact factor and consistently ranking in the Q2 category in both Immunology and Allergy and Ophthalmology, it stands out as a vital resource for researchers, clinicians, and students alike. The journal's broad scope encompasses both experimental and clinical studies, ensuring a comprehensive exploration of the mechanisms and treatments of ocular inflammatory conditions. With its publication history dating from 1993 to 2024, this journal continues to be an essential reference for those seeking cutting-edge research and insights into ocular health. Researchers and professionals are encouraged to engage with the latest articles to inform their practice and advance their knowledge in this critical area of medicine.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
Pioneering breakthroughs in ocular pharmacology.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, published by Mary Ann Liebert, Inc, stands at the forefront of research in the realms of ophthalmology and pharmacology. Established in 1985 and converging until 2024, this esteemed journal is dedicated to advancing the understanding of ocular pharmacology, drug therapies, and therapeutic approaches in the treatment of eye diseases. With an impressive impact factor and categorized in the Q2 quartile for both Ophthalmology and Medical Pharmacology, it showcases pivotal research in the field, reflecting its rank of #31 among 137 in Ophthalmology and #109 among 272 in Medical Pharmacology per Scopus metrics. Although it follows a subscription-based model, the journal provides critical insights and empirical studies that foster innovation and collaboration for researchers, professionals, and students alike in the pursuit of improving ocular health.
Journal of Current Ophthalmology
Bridging Research and Practice: Enhancing Eye Health TogetherJournal of Current Ophthalmology is a premier scholarly platform dedicated to advancing the field of ophthalmology, published by Wolters Kluwer Medknow Publications. Established as an Open Access journal since 2015, it aims to provide unrestricted access to high-quality research that fosters knowledge sharing and collaboration among researchers, practitioners, and students in the field. The journal covers a broad spectrum of topics within ophthalmology, from clinical practices to groundbreaking research, contributing significantly to the medical community's understanding of eye health and diseases. With an impact factor reflecting its significance, it ranks in the Q2 category of ophthalmology and stands at #66 out of 137 in Scopus rankings, placing it in the 52nd percentile of its field as of 2023. The Journal of Current Ophthalmology is committed to publishing cutting-edge findings and innovative solutions, establishing itself as an essential resource for all professionals engaged in ocular research and care.
Case Reports in Ophthalmology
Pioneering research for the future of eye health.Case Reports in Ophthalmology is an esteemed peer-reviewed journal published by KARGER, dedicated to advancing the field of ophthalmology through the dissemination of high-quality case reports. Since its establishment in 2010, the journal has maintained its Open Access model, ensuring that valuable research is accessible to a global audience, thus fostering collaboration and innovation in eye care. Hailing from Switzerland, the journal covers a broad range of topics within ophthalmology, providing a platform for clinicians and researchers to share unique clinical insights and pivotal findings. With a current impact factor that positions it within the Q3 category of ophthalmology in the 2023 rankings, Case Reports in Ophthalmology is a vital resource for professionals seeking to stay abreast of emerging trends and case studies in the field. Researchers and students alike will benefit from its rigorous peer-review process and its commitment to supporting quality research initiatives, making it an essential addition to any ophthalmology library.
Journal of Ophthalmic & Vision Research
Empowering Research in OphthalmologyThe Journal of Ophthalmic & Vision Research, published by KNOWLEDGE E, stands as a crucial platform for disseminating high-quality research in the field of ophthalmology. With an ISSN of 2008-2010 and an E-ISSN of 2008-322X, this journal fosters open access to valuable insights since 2010, enhancing visibility and reach for researchers globally. Based in Dubai, UAE, it has established a reputation for excellence, reflected in its Q2 ranking in Ophthalmology for 2023 and its position among the top 65th percentile in Scopus. Covering a broad spectrum of topics within ophthalmic science, the journal serves as a vital resource for professionals, researchers, and students by presenting original research, reviews, and case studies that drive innovation and collaboration within the community. As the journal continues to contribute to advancements in eye care and vision sciences, it invites scholars to explore, engage, and publish within its pages, thus enriching the global discourse on ophthalmic health.